Abstract
The liver and (small) intestine are key organs in maintenance of cholesterol homeostasis: both organs show active de novo cholesterogenesis and are able to transport impressive amounts of newly synthesized and diet-derived cholesterol via a number of distinct pathways. Cholesterol trafficking involves the concerted action of a number of transporter proteins, some of which have been identified only recently. In particular, several ATP-binding cassette (ABC) transporters fulfil critical roles. For instance, the ABCG5/ABCG8 couple is crucial for hepatobiliary and intestinal cholesterol excretion, while ABCA1 is essential for high-density lipoprotein formation and, hence, for inter-organ trafficking of the highly water-insoluble cholesterol molecules. Very recently, the Niemann-Pick C1-like 1 protein has been identified as a key player in cholesterol absorption by the small intestine and may represent a target of the cholesterol absorption inhibitor ezetimibe. Alterations in hepatic and intestinal cholesterol transport affect circulating levels of atherogenic lipoproteins and thus the risk for cardiovascular disease. This review specifically deals with the processes of hepatobiliary cholesterol excretion and intestinal cholesterol absorption as well as the interactions between these important transport routes. During the last few years, insight into the mechanisms of hepatic and intestinal cholesterol transport has greatly increased not in the least by the identification of involved transporter proteins and the (partial) elucidation of their mode of action. In addition, information has become available on (transcription) factors regulating expression of the encoding genes. This knowledge is of great importance for the development of a tailored design of novel plasma cholesterol-lowering strategies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Altmann SW, Davis HR, Yao X et al. (2002) The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochim Biophys Acta 1580:77–93
Altmann SW, Davis HR, Zhu LJ et al. (2004) Niemann-Pick C1 Like 1 Protein is critical for intestinal cholesterol absorption. Science 303:1201–1204
Berge KE, Tian H, Graf GA et al. (2000)Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290:1771–1775
Berger GM, Pegoraro RJ, Patel SB et al. (1998) HMG-CoA reductase is not the site of the primary defect in phytosterolemia. J Lipid Res 39:1046–1054
Billington D, Coleman R (1978) Effects of bile salts of human erythrocytes. Plasma membrane vesiculation, phospholipid solubilization and their possible relationships to bile secretion. Biochim Biophys Acta 509:33–47
Billington D, Coleman R (1978) The removal of membrane components from human erythrocytes by glycocholate. Biochem Soc Trans 6:286–288
Buhman KK, Accad M, Novak S et al. (2000)Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat Med 6:1341–1347
Crawford J, Crawford A R, Hatch V C et al. (1995) Hepatocellular secretion of biliary lipid: bile salt-induced vesiculation of the canalicular membrane outer leaflet. In:Hofmann AF, Paumgartner G, Stiehl A(eds) Bile acids in gastroenterology. Basic and clinical advances, Kluwer Academic Publishers, Dordrecht. pp 254–257
Crawford J, Hatch VC, Groen AK et al. (1995) Bile canalicular vesicles are markedly decreased in mdr2 knockout mice: electron microscopy of cryofixed liver. Hepatology 22:316A
Crawford J, Möckel GM, Crawford AR et al. (1995). Imaging biliary lipid secretion in the rat: ultrastructural evidence for vesiculation of the hepatocyte canalicular membrane. J Lipid Res 36:2147–2163
Davies JP, Levy B, Ioannou YA (2000) Evidence for a Niemann-Pick C (NPC) gene family: identification and characterization of NPC1L1. Genomics 65:137–145
Delsing DJ, Offerman EH, van Duyvenvoorde W et al. (2001) Acyl-CoA: cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice. Circulation 103:1778–1786
Dietschy JM, Turley SD, Spady DK (1993) Role of liver in maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res 34:1637–1659
Drobnik W, Lindenthal B, Lieser B et al. (2001) ATP-binding casette transporter A1 (ABCA1) affects total body sterol metabolism. Gastroenterology 120:1203–1211
Eckardt ERM, Wang DQ, Donovan JM et al. (2002) Dietary sphingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic avtivity of cholesterol monomers. Gastroenterology 122:948–956
Groen AK, Bloks VW, Bandsma RHJ et al. (2001) Hepatobiliary cholesterol transport is not impaired in ABCA1 null mice lacking high density lipoproteins. J Clin Invest 108:843–850
Insull W, Koren M, Davignon J et al. (2001) Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia. Atherosclerosis 157:137–144
Klett EL, Lu K, Kosters A et al. (2004) A mouse model of sitosterolemia: absence of Abcg8/sterolin-2 results in failure to secrete biliary cholesterol. BMC Med 2:5
Kosters A, Frijters RJMM, Vink E et al. (2003) Relation between hepatic expression of ATP-binding casette transporters G5 and G8 and biliary cholesterol secretion in mice. J Hepatol 38:710–716
Kuipers F, Oude Elferink RPJ, Verkade HJ, Groen AK (1997) Mechanisms and (patho)physiological significance of biliary cholesterol secretion. Sub-Cell Biochem 28:295–318
Lee MH, Lu K, Hazard S et al. (2001) Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 27:79–83
Lu K, Lee MH, Zhou Y et al. (2002) Molecular cloning, genomic organization, genetic variations, and characterization of murine sterolin genes Abcg5 and Abcg8. J Lipid Res 43:565–578
McNeish J, Aiello RJ, Gyot D et al. (2000) High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding casette transporter-1. Proc Natl Acad Sci USA 97:4245–4250
Mulligan JD, Flowers MT, Tebon A et al. (2003) ABCA1 is essential for efficient basolateral cholesterol efflux during the absorption of dietary cholesterol in chickens. J Biol Chem 278:13356–13366
Neese RA, Faix D, Kletke C et al. (1993) Measurement of endogenous synthesis of plasma cholesterol in rats and humans using MIDA. Am J Physiol 264: E136–E147
Ostlund RE (2002) Phytosterols in human nutrition. Annu Rev Nutr 22:533–549
Ostlund RE, Bosner MS, Stenson WF (1999) Cholesterol absorption efficiency declines at moderate dietary intake in normal human subjects. J Lipid Res 40:1453–1458
Oude Elferink RPJ, Bakker CTM, Roelofsen H et al. (1993). Accumulation of organic anion in intracellular vesicles of cultured rat hepatocytes is mediated by the canalicular multispecific organic anion transporter. Hepatology 17:434–444
Oude Elferink RPJ, Ottenhoff R, van Wijland M et al. (1996) Uncoupling of biliary phospholipid and cholesterol secretion in mice with reduced expression of mdr2 P-glycoprotein. J Lipid Res 37:1065–1075
Oude Elferink RPJ, Ottenhoff R, van Wijland MJA et al. (1995) Regulation of biliary lipid secretion by mdr2-P-glycoprotein in the mouse. J Clin Invest 95:31–38
Patel SB, Honda A, Salen G (1998) Sitosterolemia: exclusion of genes involved in reduced cholesterol biosynthesis. J Lipid Res 39:1055–1061
Plösch T, Bloks VW, Terasawa Y et al. (2004) Sitosterolemia in ABC-transporter G5-deficient mice is aggravated on activation of the liver X receptor. Gastroenterology 126:290–300
Plösch T, Kok T, Bloks VW et al. (2002) Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor (LXR) is independent of ABCA1. J Biol Chem 277:33870–33877
Raal FJ, Marais DA, Klepack E et al. (2003) Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia. Atherosclerosis 171:273–279
Remaley AT, Bark S, Walts AD et al. (2002) Comparative genome analysis of potential regulatory elements in the ABCG5-ABCG8 gene cluster. Biochem Biophys Res Commun 295:276–282
Repa JJ, Berge KE, Pomajzl C et al. (2002) Regulation of ATP-Casette sterol transporters ABCG5 and ABCG8 by the liver X receptors α and β. J Biol Chem 277:18793–18800
Repa JJ, Mangelsdorf DJ (2002) The liver X receptor gene team: potential new players in atherosclerosis. Nat Med 8:1243–1248
Salen G, Patel SB, Batta AK (2002) Sitosterolemia. Cardiovasc Drug Rev 20:255–270
Graf GA, Li WP, Gerard RD et al. (2002) Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J Clin Invest 110:659–669
Schaeffer EJ, Bruosseau ME, Diffenderfer MR et al. (2001) Cholesterol and apolipoprotein B metabolism in Tangier disease. Atherosclerosis 159:231–236
Schulthess G, Compassi S, Werder M et al. (2000) Intestinal sterol absorption mediated by scavenger receptors is competitively inhibited by amphipathic peptides and proteins. Biochemistry 39:12623–12631
Schwarz M, Davis DL, Vick BR et al. (2001) Genetic analysis of intestinal cholesterol absorption in inbred mice. J Lipid Res 42:1801–1811
Schwarz M, Russell DW, Dietschy JM et al. (2001) Alternate pathways of bile acid synthesis in the cholesterol 7α-hydroxylaseknockoutmouse are not upregulated by either cholesterol or cholestyramine feeding. J Lipid Res 42:1594–1603
Sehayek E, Duncan EM, Lütjohann D, et al. (2002) Loci on chromosomes 14 and 2, distinct from ABCG5/ABCG8, regulate plasma plant sterol levels in a C57BL/6 J x CASA/Rk intercross. Proc Natl Acad Sci USA 99:16215–16219
Small DM (2003) Role of ABC transporters in secretion of cholesterol from liver into bile. Proc Natl Acad Sci USA 100:4–6
Smart EJ, De Rose RA, Farber SA (2004) Annexin2-caveolin1 complex is a target of ezetimibe and regulates intestinal cholesterol transport. Proc Natl Acad Sci USA 101:3450–3455
Smit JJ, Schinkel AH, Oude Elferink RPJ et al. (1993). Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451–462
Stellaard F, Sackmann M, Sauerbruch T et al. (1984) Simultaneous determination of cholic acid and chenodeoxycholic acid pool sizes and fractional turnover rates in human serum using labeled bile acids. J Lipid Res 25:1313–1319
Sudhop T, von Bergmann K (2002) Cholesterol absorption inhibitors for the treatment of hypercholesterolemia. Drugs 62:2333–2347
Sudhop T, Lütjohahn D, Kodal A et al. (2002) Inhibition of cholesterol absorption by ezetimibe in humans. Circulation 106:1943–1948
Temel RE, Gebre AK, Parks JS et al. (2003)Compared with acyl-CoA: cholesterol O-acyltransferase (ACAT) 1 and lecithin: cholesterol acyltransferase, ACAT2 displays the greatest capacity to differentiate cholesterol from sitosterol. J Biol Chem 278:47594–47601
Turley SD, Dietschy J (2003) Sterol absorption by the small intestine. Curr Opin Lipidol 14:233–240
Van Heek M, France CF, Compton DS et al. (1997) In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. J Pharmacol Exp Ther 283:157–163
Verkade HJ, Havinga R, Gerding A et al. (1993) Mechanism of Bile Acid-Induced Biliary Lipid Secretion in the Rat: Effect of Conjugated Bilirubin. Am J Physiol 264: G462–G469
Verkade HJ, Vonk RJ, Kuipers F (1995). New insights into the mechanism of bile acid induced biliary lipid secretion. Hepatology 21:1174–1189
Voshol PJ, Minich DM, Havinga R et al. (2000) Postprandial chylomicron formation and fat absorption inmultidrug resistance gene 2 P-glycoprotein-deficient mice. Gastroenterology 118:173–182
Voshol PJ, Schwarz M, Rigotti A et al. (2001) Down-regulation of intestinal scavenger receptor class B, type I (SR-BI) expression in rodents under conditions of deficient bile delivery to the intestine. Biochem J 356:317–325
Wang DQ, Carey MC (2003) Measurement of intestinal cholesterol absorption by plasma dual-isotope ratio, mass balance, and lymph fistula methods in the mouse: an analysis of direct versus indirect methodologies. J Lipid Res 44:1042–1059
Wang DQ, Tazuma S, Cohen DE (1999) Natural hydrophilic bile acids profoundly inhibit intestinal cholesterol absorption in mice. Hepatology 30:395A
Wellington CL, Walker EK, Suarez A et al. (2002) ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation. Lab Invest 82:273–283
Werder M, Han CH, Wehrli E et al. (2001) Role of scavenger receptors SR-BI and CD36 in selective sterol uptake in the small intestine. Biochemistry 40:11643–11650
Wilson MD, Rudel LL (1994) Review of cholesterol absorption with emphasis on dietary and biliary cholesterol. J Lipid Res 35:943–955
Wittenburg H, Lyons MA, Li R (2003)FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice. Gastroenterology 125:868–881
Young SG, Cham CM, Pitas RE et al. (1995) A genetic model for absent chylomicron formation: mice producing apolipoprotein B48 in the liver, but not in the intestine. J Clin Invest 96:2932–2946
Yu L, Hammer RE, Li-Hawkins J et al. (2002A) Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci USA 99:16237–16242
Yu L, Li-Hawkins J, Hammer RE et al. (2002B) Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 110:671–680
Yu L, York J, von Bergmann K et al. (2003) Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J Biol Chem 278:15565–15570
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Plösch, T., Kosters, A., Groen, A., Kuipers, F. (2005). The ABC of Hepatic and Intestinal Cholesterol Transport. In: von Eckardstein, A. (eds) Atherosclerosis: Diet and Drugs. Handbook of Experimental Pharmacology, vol 170. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27661-0_17
Download citation
DOI: https://doi.org/10.1007/3-540-27661-0_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22569-0
Online ISBN: 978-3-540-27661-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)